Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy
Author(s) -
ChengKun Wu,
KuoChin Chang,
Chao–Hung Hung,
PoLin Tseng,
ShengNan Lu,
ChienHung Chen,
JingHoung Wang,
Chuan–Mo Lee,
MingChao Tsai,
MingTsung Lin,
YiHao Yen,
TsungHui Hu
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw097
Subject(s) - hepatocellular carcinoma , platelet , medicine , antiviral therapy , gastroenterology , chronic hepatitis , immunology , virus
Hepatitis C virus (HCV)-infected patients who achieve viral eradication may still develop hepatocellular carcinoma (HCC). Little is known about the impact of dynamic change of serum markers on HCC development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom